Polycystic Ovarian Syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention: The questionnaires were included height, weight, body mass index, waist, menstruation pattern, infertility.Tests, fasting glucose, fasting insulin, insulin resistance index were measur
Treatment - Drugs
Sponsors
Vice chancellor for research, Shahid Beheshti University of Medical Science
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Women who were between 20 and 40 years old, were vitamin D deficient, and had PCOS diagnosed by a gynecologist Exclusion criteria: Patients who were diagnosed with Cushing syndrome, congenital adrenal hyperplasia, hyperprolactinemia, hypothyroidism, hyperthyroidism, andogen secreting tumor, all systemic disease affect vitamin D level such as liver disease, renal dysfunction, malabsorption syndrome, alcholism, lactation, pregnancy, medications known to affect metabolic parameters, such as metformin and corticosteroid drugs,vitamin D, and serum calcium
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting glucose. Timepoint: Before intervention and two months after vitamon D injection. Method of measurement: Blood serum.;Fasting insulin. Timepoint: Before intervention and two months after vitamon D injection. Method of measurement: Blood serum.;HOMA IR. Timepoint: Before intervention and two months after vitamon D injection. Method of measurement: Calculation by formula. | — |
Secondary
| Measure | Time frame |
|---|---|
| Height. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Meter.;Weight. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Balance.;25 hydroxy vitamin D. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Blood serum.;Body Mass Index. Timepoint: Before intervention and two months after vitamin D injection. Method of measurement: Formola. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Saghar salehpour
Infertility & Reproductive Health Research Centre - Shahid Beheshti of Medical Science
Outcome results
None listed